Latest Breaking News On - Carly scaduto - Page 1 : comparemela.com

Vir Biotechnology, Inc : Multiple Abstracts Highlighting Vir Biotechnology s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024

- Company to present important new data from the Phase 2 SOLSTICE chronic hepatitis delta trial - - Conference call scheduled for June 5, 2024, at 6:00 a.m. ET 12:00 p.m. CEST - Vir Biotechnology

France generalSnehav guptaCarey hwangCarly scadutoAndrea cathcartRichard lepkeTarik asselahAlnylam pharmaceuticals incUniversity of parisClinical researchExchange commissionVir biotechnology incEuropean associationLiver diseasesSenior vice presidentInterim chief medical

Vir Biotechnology, Inc : Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the EASL Congress has changed the Company's Phase 2 SOLSTICE hepatitis delta presentation from a late-breaker poster to an oral presentation. The

Carly scadutoRichard lepkeAlnylam pharmaceuticals incExchange commissionVir biotechnology incCompany phaseVir biotechnologyEuropean associationLiver diseasesEnhanced stabilization chemistry plusAlnylam pharmaceuticalsPrivate securities litigation reform actExternal communicationsInvestor relationsIhr portfolio

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCarly scadutoRichard lepkeFontainebleau hotel in miami beachVir biotechnology incHealth care conferenceAnnual health care conferenceBoston marriott copley placeMarianne de backerChief executive officerPartners global biopharma conferenceFontainebleau hotelAnnual global healthcare conferenceLoews miami beach hotelVir biotechnologyMedia relations

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on Feb

SAN FRANCISCO (BUSINESS WIRE) $VIR Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the fourth quarter ended December 31, 2023, on February 22, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. East.

Carly scadutoVir biotechnology incVir biotechnologyPress releasesMedia relations

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sasha damouni ellisCarly scadutoCorporate affairsVir biotechnology incPress releasesVir biotechnologyMedia relationsVice presidentChief corporate affairs officer